WASHINGTON (AP) The U.S. Food and Drug Administration is moving ahead with a crackdown on scores of COVID-19 antibody tests that have not yet been shown to work.
U.S. regulators on Thursday published a list of more than two dozen companies that failed to file applications to remain on the market or have already pulled their products.
The FDA previously allowed the tests to launch with virtually no oversight.
The agency reversed that policy after critics said it had created a “Wild West” of unregulated tests.
The blood tests are designed to detect for past coronavirus infections.